Continuous positive airway pressure (CPAP) is the first-line treatment for the majority of patients affected by obstructive sleep apnea syndrome (OSA). However, long-term compliance with CPAP therapy may result limited and alternatives to CPAP therapy are required to address the increasing need to provide tailored therapeutic options. Understanding the pathophysiological traits (PTs) of OSA patients [upper airway (UA) anatomical collapsibility, loop gain (LG), arousal threshold (AT), and UA gain (UAG)] lies at the heart of the customized OSA treatment. However, sleep research laboratories capable to phenotype OSA patients are sparse and the diagnostic procedures time-consuming, costly, and requiring significant expertise. The question arises whether the use of routine clinical polysomnography or nocturnal portable multi-channel monitoring (PSG/PM) can provide sufficient information to characterize the above traits. The aim of the present review is to deduce if the information obtainable from the clinical PSG/PM analysis, independently of the scope and context of the original studies, is clinically useful to define qualitatively the PTs of individual OSA patients. In summary, it is possible to identify four patterns using PSG/PM that are consistent with an altered UA collapsibility, three that are consistent with altered LG, two with altered AT, and three consistent with flow limitation/UA muscle response. Furthermore, some PSG/PM indexes and patterns, useful for the suitable management of OSA patient, have been discussed. The delivery of this clinical approach to phenotype pathophysiological traits will allow patients to benefit in a wider range of sleep services by facilitating tailored therapeutic options.
Introduction
Continuous positive airways pressure (CPAP) is the first-line treatment for the majority of patients affected by obstructive sleep apnea syndrome (OSA) and represents the paradigm of Bone-size-fits-all^therapeutic strategy [1] . However, long-term compliance with CPAP therapy is limited and alternatives to CPAP therapy are therefore required to address the increasing need to provide tailored therapeutic options ( [2] [3] [4] ). In this context, it is important to focus on the patients' pathophysiologic traits (PTs).
In OSA, PTs can be phenotyped in sleep laboratories by applying positive airway pressure device, with the patient in supine position, during non-rapid eye movement sleep (NREM) stage 2. At the same time, ventilation is recorded while changing upper airway (UA) pressure. Four different PTs have been identified: upper airway anatomical collapsibility (UA anatomical trait), loop gain (LG trait), arousal threshold (AT) trait, and upper airway gain (UAG) trait [5] [6] [7] .
Although the presence of predisposition to UA anatomical collapsibility is important in the concept of apneic events, it may not be the leading factor for the development of OSA as apneas and hypopneas may be caused as a result of the nonanatomical PTs (LG, AT, UAG) [7] . In some patients with OSA, UA anatomical collapsibility can be critical to produce the apneic events, independent of any other PTs (inevitable OSA); other patients without sufficient UA anatomical collapsibility do not develop OSA, even in the presence of significant features of other PTs. Finally, there are different grades of anatomical collapsibility (UA vulnerable anatomy) and patients only develop apneic events depending on the presence of any of the other three pathophysiological traits, LG, AT, and UAG [7] .
Eckert et al. [8] proposed a possible classification of OSA patients in three subgroups, based on the impairment of UA anatomy and the non-anatomical phenotypes ( LG, AT, and UAG), the Pcritical, arousal threshold, loop gain, muscle responsiveness (PALM) scale. This kind of phenotyping introduced different possible therapeutic strategies which, however, have only been developed on small clinical groups and with theoretical models [3, 7, 8] :
& PALM scale 1: A subgroup of patients (23%), who are characterized by a critical occlusion pressure (Pcrit) above + 2 cmH 2 O with high passive anatomical collapsibility, develop apneic events due to anatomical factors, independent of other non-anatomical pathophysiological traits; this is called Binevitable OSA^. In these patients, treatment options focus on the anatomical basis [e.g., CPAP, mandibular advancement device (MAD), UA surgery, positional therapy, weight loss]. & PALM scale 3: A subgroup of patients (19%) that is characterized by a Pcrit lower than -2 cmH 2 O with a low passive collapsibility, develop apneic events due to nonanatomical pathophysiological factors (LG, AT, UAG). Eckert et al. suggest that in these patients, the treatment has to target the putative factor of instability by means of single or combined treatment (i.e, oxygen therapy and/or drugs active on LG and AT). & PALM scale 2: A subgroup of patients (58%) who show a relatively high passive collapsibility characterized by a Pcrit between + 2 and -2 cmH 2 O. They are subdivided into subgroup 2a, which relates to anatomical pathophysiological factors (inevitable OSA), and subgroup 2b, which relates to anatomical and non-anatomical pathophysiological factors prevalence. Eckert et al. thought that the predominant therapeutic approach for subgroup 2a is the anatomical basis (CPAP, mandibular advance splint, upper air way surgery, positioning therapy, weight loss), while subgroup 2b may be treated using anatomical and non-anatomical treatment options.
Understanding the PTs lies at the heart of the customized OSA treatment [7] but nowadays, the sleep research laboratories capable to phenotype OSA patients are available only in few centers of excellence and the procedures are timeconsuming and costly and require expertise, albeit some new novel and non-invasive methods for characterizing and quantifying some of the pathophysiological phenotypes have been recently introduced [9, 10] . Nevertheless, the question remains whether the use of routine clinical polysomnography or nocturnal portable multi-channel monitoring (PSG/PM) can provide useful information, at least to define qualitative definition properties of the different PTs of OSA.
The aim of present review is to collect the information obtainable from the clinical PSG/PM analysis, independent of the scope and context of the original studies, useful to define a model of PTs characterization of the single OSA patient without depending on experimental procedures. Furthermore, some PSG/PM indexes and patterns, useful for the suitable management of OSA patient, have been discussed.
The upper airway anatomical collapsibility
UA anatomical collapsibility has been defined by means of the passive Pcrit that describes the endolaryngeal pressure threshold [11, 12] . The Pcrit maneuvers are difficult to establish in clinical routine, because of the required technological equipment, time, and expertise needed, the complexity in obtaining and interpreting the pressure/volume curves, and the difficulties in obtaining defined sleep stages during the maneuver. Although this does not negate physiological usefulness of the concept, it substantially limits clinical availability of this method which can be inferred by the high percentage of physiological studies in OSA that fail to gather these data. Moreover, there is little standardization of the diagnostic protocol which limits comparability between available studies using this method [13] .
The current literature review has focused on the link between the PSG/PM data and the UA anatomical collapsibility, taking into account that data have to be linked to the different sensors and scoring standards applied by different studies.
Predominant obstructive apneic pattern It represents a PSG/ PM marker useful to identify patients with high collapsibility of the upper airway. Gleadhill et al. [14] reported that OSA characterized by a predominant obstructive apneic pattern [where obstructive apneas represent at least 90% of the total apnea-hypopnea index (AHI; Fig. 1 )] were likely to have a Pcrit value of > 2 cmH 2 O. The patients studied had predominantly severe OSA (AHI 70 ± 24/h) and were studied using nasal and oral thermistor and defining obstructive apnea as the absence of airflow and hypopnea as the airflow reduction of 50%, associated with a ≥ 3% desaturation or with an arousal. This information is helpful in understanding that predominant obstructive apneic PSG/PM patterns are linked to a high UA anatomical collapsibility, which is described as PALM scale 1.
Upper airway resistance syndrome pattern It is coherent with low UA anatomical collapsibility. Gold et al. [15] reported that patients affected by upper airway resistance syndrome (UARS) showed a PSG/PM pattern characterized by respiratory effort-related arousals (RERAs; Fig. 2 ), which is linked to a Pcrit lower than − 2 cmH 2 O. Thus, UARS patients match the PALM scale 3 which is characterized by a low upper airway anatomical collapsibility and a significant role of nonanatomical PTs. The PSG scoring standards applied by the authors for the respiratory effort-related arousal (RERA) and UARS are not strictly coherent to the current and more accepted definitions [16, 17] . AHI severity pattern It is possible to gather information concerning the UA anatomy promoting pharyngeal collapsibility by the analysis of apnea-hypopnea index (AHI) severity. The data by Eckert et al. [8] indicated that it is possible to analyze the relation between the Pcrit value and AHI severity and showed that only 10.3% (3/29) of the OSA patients with an AHI of > 40/h had a Pcrit lower than − 2 cmH 2 O (PALM scale 3), whereas only 3.7% (1/27) of the patients with AHI of < 40/h had a Pcrit higher than + 2 cmH 2 O (PALM scale 1).In summary, OSA patients with AHI of > 40/h have a low risk to be included in PALM 3 scale classification as well as OSA patients with AHI of < 40/h have a low risk to be included in the PALM 1 scale. These information cannot be generally applied to PSG/PM without taking into account the sensors and scoring standards used by the authors in the study [18] , which are not those currently recommended by the AASM [19] .
Therapeutic CPAP value Landry et al. [20] found that patients with a mildly collapsible UA (Pcrit ≤ − 2 cmH 2 O) required lower therapeutic CPAP and found that a therapeutic CPAP level of ≤ 8.0 cmH 2 O (overall therapeutic control of apneas, hypopneas, inspiratory flow limitation, and snoring during NREM sleep stage) was sensitive (89%) and specific (84%) for detecting a mildly collapsible UA. When applied to the independent validation dataset (n = 74), this threshold maintained a high specificity (91%) but resulted in reduced sensitivity (75%). Therefore, the level of therapeutic CPAP may be used to accurately differentiate OSA patients with mild airway collapsibility (PALM scale 3) from those with moderate-tosevere collapsibility (PALM scale 2 and 1).
Loop gain and ventilatory control
The ventilatory control helps to maintain the homeostasis of the blood gas and it is state-and sleep-stage-dependent, with supra-pontine effects during wakefulness and during REM sleep and predominantly metabolic control during NREM sleep stages. The metabolic complexity of ventilatory control during NREM sleep has been simplified and summarized by the engineering model of loop gain (LG), which consists of one control component (chemoreceptor: controller gain), one exchange component (lung: plant gain), and one connection component (circulation: circulatory delay). The responsiveness of LG is measured in no dimensional unit; a LG of > 1 is related to a very efficient and hyper-reactive system, which determines a quick and excessive ventilatory response (periodic breathing) to a destabilizing respiratory events during sleep, whereas a LG < 1 is related to a low ventilatory response to a destabilizing event during sleep with a rapid new balance of the system [21] .
Periodic breathing with Cheyne-Stokes respiration (CSR) is characterized by a Bwaxing and waning^respiratory effort and represents the most know sleep disturbance caused by ventilatory metabolic control instability (high LG). Sands et al. reported a rapid method for calculating the LG on patients affected by heart disease with CSR by means of graphic elements from clinical PSG trace [22] .
The high LG represents an important PTs also in a significant percentage of OSA patients. The LG can be measured by means of a bi-level positive pressure device, UA continuous pressure devices [3, 23, 24] or sophisticated mathematical analysis of clinical PSG/PM [10] . Nowadays, these techniques of LG measurement are not available in clinical routine, but it is possible to obtain information related to high ventilatory control instability during sleep from clinical PSG/PM recordings. Mixed OSA-CSR pattern This is a relatively common pattern, consisting of alternation and mixing periods characterized by UA obstructive events and CSR periods [25] . The presence of CSR has to be considered a PSG/PM pattern related to instability of ventilatory metabolic control and a hyper-responsive LG.
Predominant obstructive pattern with some central/mixed events This pattern is identified by using PSG/PM and is characterized by a predominant obstructive pattern with some percentage of central/mixed events (Figs. 3-4) . This is another pattern related to instability of ventilatory metabolic control and a hyper-responsive LG. The ventilatory instability control is due to two main factors: the LG control system and the CO 2 reserve. The CO 2 reserve is defined as the difference between the PaCO 2 value during eupneic ventilation sleep and the PaCO 2 value at which the apneic event occurs [26] . A high LG determines periodic breathing, whereas a low CO 2 reserve can produce central respiratory events, which occur during the decreasing phase of ventilation during periodic breathing [27] . Xie et al. [28] studied 21 OSA patients, identifying two subgroups: the first subgroup consisted of 9 patients with obstructive PSG pattern and a second subgroup consisted of 12 patients with a PSG pattern that was characterized by predominant obstructive events and a percentage of central/mixed events (28.2 ± 6.3%), which were related to a high CO 2 chemo-responsiveness with low CO 2 reserve and consequent central/mixed events. The authors did not report a different Pcrit between the two subgroups, which would be related to anatomical UA collapsibility.
Predominant NREM OSA pattern OSA can be classified in relation to the predominant sleep stages (NREM vs REM). Joosten et al. [29] studied 1064 patients with OSA reporting predominantly REM-related OSA in 45.3% of patients (AHI-REM:AHI-NREM > 2), isolated REM-related OSA in 13.6% of patients (AHI-REM:AHI-NREM > 2 with AHI-NREM < 5/h) and OSA during predominantly NREM sleep in 18.9% of patients (AHI-REM:AHI-NREM < 0.5). In NREM sleep stage, ventilator control is exclusively metabolic, whereas in REM sleep stage is mixed: metabolic and behavioral. Obstructive respiratory events in predominantly REM-related OSA are characterized by significant muscular hypotonia/atonia and lower chemo-responsiveness [30, 31] , whereas predominantly NREM-related OSA may be characterized by an unstable ventilatory metabolic control during NREM sleep stage, which is related to a high LG. In patients with predominantly NREMrelated OSA, the supra-pontine control is active during REM sleep and determines the improvement of apneic events when transitioning from NREM (a state of instability of the ventilatory metabolic control characterized by a high LG) to REM sleep (a state of increased stability of the ventilatory control, which now is not exclusively metabolic but mixed metabolic/behavioral). Terril et al. [10] suggested a method of LG measurement in 28 patients with moderate-severe OSA based on the clinical PSG analysis. The authors reported a significant correlation between high LG and predominantly NREM-related OSA (r = − 0.46, p = 0.02) and suggested that a difference between the REM-AHI and NREM-AHI that is higher than 25 events is related to a LG of > 1. Moreover, the authors reported a significant correlation between LG and post-apneic event hyperventilation (r = − 0.60, p < 0.001) and inter-event pause (r = −0.56, p = 0.001); the regression analysis of the patients with post-apneic event hyperventilation duration ≤ 12 s and with an inter-event pause ≤ 30 s are characterized by a LG of ≥ 1. In summary, predominantly NREM-related OSA has a PSG pattern that is characterized by a high LG.
The arousal threshold AT is defined as the level of inspiratory effort, measured by the esophageal pressure, at which obstructive events terminate, usually with an arousal from sleep [32, 33] . For a long time, arousals from sleep have been considered as unavoidable and necessary for ending an obstructive event. However, in more than 25% of obstructive events, arousals may not be observed at the end of the obstructive event [34] [35] [36] . During an obstructive event, Bnon-muscular^(increasing inspiratory flow, duty cycle, and respiratory frequency) and Bmuscular^mecha-nisms are recruited via chemical and mechanical triggers. When these mechanisms achieve a balance to obtain sufficient ventilation (sustainable VE) then an arousal may not be required to achieve ongoing ventilation. The threshold of the UA reopening, sufficient to achieve a sustainable VE, is defined as threshold of effective recruitment (Ter). Essentially, the relation between the AT and Ter determines whether there is an arousal at the end of an obstructive event; the arousal occurs when the AT is lower than Ter or when hyperventilation follows UA reopening and stimulates the arousal center [37, 38] . AT and Ter are related to sleep stage and to other factors, such as age, drugs, alcohol consumption, sleep fragmentation, and sleep deficiency [29] . Finally, the arousal intensity could represent an independent pathophysiological trait; high arousal intensity is related to increased ventilation and unstable ventilatory control [39] .
Low AT pattern A low AT can be characterized by three PM/ PSG parameters. Edwards et al. [9] studied 147 patients by means of PSG and epiglottic catheter and found independent predictors of AT. They developed a PSG score based on three parameters, an AHI of < 30/h, associated with oxygen desaturating of a nadir SpO 2 > 82% and with a hypopnea:apnea ratio of > 58.3%, which was useful to identify a low AT; 2/3 of these scores predict a low AT in 84.1% of patients with a sensitivity of 80.4% and specificity of 88%. Consequently, UARS (Fig. 5) characterized by a low collapsibility, normal AHI range, and RERAs is an extreme version of this low AT pattern [11] .
High AT pattern A PSG characterized by prolonged and severe desaturations is consistent with a high AT, especially in patients with severe AHI (Figs. 6 and 7) . The desaturation nadir of an UA obstructive event is mainly dependent on two factors: the first factor is represented by the AT which is sleep-stage-dependent (NREM 1 equals the one at REM and it is higher in NREM 2 and NREM 3); it increases with the sleep fragmentation, chronic sleep deficiency, and AHI severity [9] . The second factor is represented by the slope of ventilatory response to the hypoxemic and hypercapnic stimuli which are also sleep-stage-dependent [28] . These two factors allow the interpretation of the different severity of desaturation nadir, which are, for example, observed during NREM 1 and REM sleep stages, characterized by the same AT but different chemo-responsiveness slope. In summary, these observations suggest that prolonged and severe desaturations on PSG/PM are related to a reduced ventilatory response to a chemical stimulus and a high AT.
In summary, from a clinical point of view, OSA patients affected by low AT, especially UARS patients, are included in PALM subgroup 3, whereas OSA patients reporting high AT have to avoid treatment's protocols which increase the AT or which decrease the chemo-responsiveness.
Upper airway gain
The UAG defines the UA neuromuscular recovery in response to an obstructive event. The UA collapse during obstructive events can be recorded with three different flow-limited patterns during PSG/PM, all of which are characterized by negative effort dependence (NED): the appearance of a plateau or airflow reduction, even with increased inspiratory effort [40, 41] :
-The Starling resistor model (NED pattern 1): during an obstructive event, it is possible to observe a first phase during a single inspiration during which flow increases in a linear way with increasing effort and the second phase during which flow remains stable and independent of any effort. In this model, the inspiratory flow limitation persists for all inspiratory efforts during an obstructive event. °8 ). The inspiratory flow limitation is not stable during the single inspiratory act but it is the same for all inspiratory acts of the obstructive event -Intra-event negative effort dependence pattern (NED pattern 2) (Fig. 5) : following the first phase in which the flow increases in a linear way, flow gradually decreases during the second part of the inspiration. The level of inspiratory flow limitation is repeated stereotypically for all parts of the same obstructive event. -Inter-and intra-event negative effort dependence pattern (NED pattern 3) (Fig. 8) : after the first phase during which flow increases in a linear way, flow gradually decreases during the second part of the inspiration. This inspiratory flow limitation gets progressively worse during every part of the obstructive event.
The collapse pattern of the airflow is related to different capacities of the UA to defend patency against the negative effort dependence and can also be used to identify the site of collapse. The Starling resistor pattern (a small plateaued flow limitation pattern) seems to be related to the site of collapse at the base of the tongue (a small amount of NED), whereas the two other patterns of negative effort dependence seem to be related to weaker structures such as the soft palate, lateral pharyngeal walls (large NED) and the epiglottis (severe NED) [42] .
Further PSG/PM patterns useful for clinical management
Besides the PTs, it could be possible to get much more information (indexes and patterns) from specific PSG/PM OSA severity Although the AHI represents the index most reported in the literature for the OSA diagnosis, it does not represent the best parameter related to the OSA severity [43] [44] [45] [46] ; it does not describe the different pathophysiological/clinical impact of apneas compared to hypopneas, of the oxygen desaturation severity, of the obstructive event and oxygen desaturation duration time, of the nocturnal time course of sleep events, and of the overall exposure level to the breathing disorder [45, 46] .
The total duration or the morphology of the respiratory and oxygen desaturation events is not currently evaluated when considering the severity of the disease, but the increasing length of apnea and hypopnea events are linked to longer and deeper desaturation events, which are physiologically more stressful and may have more severe consequences (on autonomic balance, hemodynamic and cardiovascular risk, systemic inflammation, vigilance, and daytime sleepiness) than shorter and shallower desaturation events.
Kulkas et al. [47] reported that these PSG/PM parameters, bringing information concerning the obstruction duration and its severity, showed a significant variability between the patients who had similar AHI showing the inadequacy of AHI as unique descriptor of OSA severity. Muraja-Murro et al. [48] calculated the AHI adjusted on the obstruction severity parameter (the sum of the products of apnea and hypopnea durations and related oxygen desaturation areas normalized with total analyzed time), observing that the risk ratios of all-cause mortality and cardiovascular morbidity were higher in moderateto-severe OSA groups based on the adjusted AHI parameter than in those based on conventional AHI. The same author [49] showed that the obstruction severity index is able to provide valuable prognostic information and might improve recognition of the patients with the highest mortality risk. Comparing 113 deceased OSA patients with alive OSA patient with similar AHI, age, body mass index (BMI), smoking habits, and follow-up time, the deceased patients with AHI of > 30 showed higher obstruction severity values than their AHI-matched alive controls. Based on the multivariate logistic regression analysis, obstruction severity was the only Fig. 7 High arousal threshold (AT). Long-lasting and severe desaturation obstructive events in delta waves of sleep, a pattern consistent with high AT parameter which was related statistically significantly to mortality in the severe OSA category.
The percentage of apneas represents another significant data for the severity evaluation; in comparison with hypopneas, the apneas provide oxygen desaturations more severe in terms of duration, area, and depth, and the duration of obstruction events (both apneas and hypopneas) determines the severity of oxygen desaturation [50] . In mild-to-moderate OSA patients, the integrated area of oxygen desaturation (IAD) is higher in patients with cardiovascular events (CVEs), compared with patients without CVEs and multivariate analysis demonstrated that the IAD was an independent variable for CVEs [51] .
To our knowledge, many but not all of these indexes are available at the present time for clinical use.
REM OSA and nocturnal time course of respiratory events Otero et al. [52] reported that the duration of apneas, hypopneas, and desaturations (AHDI) related to the total sleep time (TST) represents a better OSA diagnostic index than AHI alone. Also, the total duration of apnea-hypopnea events related to the TST (TAHD%) represents another OSA severity index, interesting and easy to determine, which can exceed the 70% of all time analyzed in severe grade of OSA patients; the breathing cessation for many hours per night can cause an increase of the physiopathologic load and, mainly, of the cardiovascular risk [53] .
The REM OSA affects 45.3% of OSA patients [29] and it may influence long-term glycemic control [54] ; it is not only cross-sectionally and longitudinally associated with hypertension but it is also independently associated with non-dipping blood pressure; this is clinically relevant because the CPAP treatment of OSA is often limited to the first half of the night, leaving most of REM sleep untreated [55, 56] . Considering the long duration of apneic-hypopneic events during REM sleep stage, it is interesting to remark that the longer the obstructive apneic events are, the more severe the periapneic hemodynamic effects (especially during the ten heartbeat after the obstructive event), in comparison with shorter apneic events [57] .
PSG pattern in female A female OSA patient has been reported a longer sleep latencies, greater amounts of slow wave sleep, a fewer awakenings during the night, a more frequent milder OSA with events occurring predominantly during REM sleep stage, and low incidence of positional OSA, in Fig. 8 Inter and intra-act negative dependence pattern. In this pattern, the inspiratory flow limitation gets progressively inter and intra-act worse during the same obstructive event comparison with OSA male patients. In the female OSA patients, the percentage of apneic events and their duration is inferior to male OSA patients [58] . However, in the female OSA patients, the longest apneas are associated with to a more severe oxygen desaturation [59] . Finally, the female OSA pattern characterized by a significant high percentage of hypopneas and respiratory effort-related arousal (RERA) events [60] has inspired the development of Auto CPAP, working by increasing sensitivity to flow limitation and optimizing the response to these events, with the control of OSA at a lower pressure [61, 62] .
Positional OSA (POSA) Body position can have a significant impact on UA anatomy and UAG. Joosten et al. [63] demonstrated in 20 OSA patients that the lateral position results in a significant improvement of UA collapsibility and UAG, with no consequences in LG and AT. The Pcrit decreased by a mean of 4 cmH 2 O, changing from the supine to lateral position, with a stabilization of the UA lumen in 7/20 OSA patients studied. The same author believed that the administration of an AT pharmacological stabilizer, but not a drug active on LG, could treat patients with residual high AHI in lateral position [29] .
However, the apneas are more frequent and longer in the supine position than in non-supine position. Furthermore, in supine position, the oxygen desaturation depth is more severe in all grades of AHI severity and only for AHI of > 15 the oxygen desaturation area associated with the apnea is larger [64] . Comparing non-supine with supine OSA patients in AHI of > 30 showed higher cardiovascular mortality and non-fatal cardiovascular events risk ratios [65] .
Discussion
About 50% of patients with sleep-disordered breathing, who use CPAP therapy, are either partially (less than 4 h per night) or entirely non-compliant with CPAP application [65] . Current non-CPAP therapies (weight loss, MAD, UA stimulation, and UA surgery) provide variable results that are often poorly predictable. So far, therapeutic strategies for OSA do not systematically consider different pathophysiological phenotypes as an essential aspect of a decision-making algorithm.
Only recently, the therapeutic approach of Bone-size-fitsall^has been overcome and new non-CPAP therapies are coming in, based on pathophysiological characteristics of an individual patient. The PALM scale allows identification of three clusters of OSA patients [8] .
The sleep laboratory phenotyping procedure of pathophysiological SDB/OSA traits is currently not available to the most sleep centers or in clinical routine, in addition to potentially useful non-CPAP therapies (mainly drugs and oxygen) aiming to treat these three PTs (LG, AT, and UAG) are not available for most patients because of a lack of appropriate clinical validation studies. However, the analysis of data reported in this review shows that data recorded in PSG/PMs allow a qualitative characterization of all these clinical traits and we believe that this pragmatic approach offers the background for polycentric studies in the clinical setting.
It is reasonable that UA surgery is one of the clinical field in which the application of this approach is more strongly interesting, also taking into account that operating services have databases available for retrospective studies and therapeutic instrumentation is easily coded and identified for prospective studies. Moreover, considering that UA surgery can change both the passive characteristics of collapsibility and the reflex component deriving from proprioceptors of the palate, the understanding of the underlying PTs is crucial for trying to analyze the surgical failure and for a better patient selection. If the grade of UA collapsibility (Pcrit), AT, and LG are known, the outcomes of surgical therapy will be more understandable; for the same reduction of Pcrit obtained, different grades of successful outcomes might be available in relation to the impact of other identified PTs. A good example is the only study, to our knowledge, that reported a decreasing Pcrit following UA surgical therapy (uvulopharyngopalatoplasty, UP3) in 13 OSA patients; a subgroup analysis of responders and nonresponders demonstrated that significant differences in Pcrit were confined to the responders. Specifically, responders demonstrated a significant fall in Pcrit from − 0.8 ± 3.0 to − 7.3 ± 4.9 cmH 2 O (p = 0.01), whereas no significant change in Pcrit was detected in the non-responders (1.1 ± 1.6 versus 0.6 ± 2.0 cmH 2 O; p = NS) [66] . Recently, electrical neurostimulation has become clinically available in OSA and in the future, the polygraphic pattern of the muscular response could be taken into account, if this approach is considered [67] [68] [69] .
Regardless of PTs, some clinical PSG/PM patterns and indexes may significantly improve the clinical management of OSA patients. However, the knowledge and use of these PSG/PM patterns and indexes represents another way for customizing the OSA therapy.
The integration of AHI with duration of apneas-hypopneas and the duration and depth of oxygen desaturation event may allow to a more accurate OSA severity assessment. Likewise, the total duration of apneas-hypopneas events related to the TST (TAHD%) and the sleep-stage-related OSA may represent important data to take into account for the OSA severity evaluation and treatment choice. In summary, the definition of OSA severity should be strictly related to a multiparametric evaluation.
The female PSG/PM pattern characterized by a significant percentage of hypopnea-RERA events has determined the development of Auto CPAP with gender-specific algorithm.
Positional therapy (PT) represents an efficient treatment option for the PSG/PM pattern of POSA. Studies on PT in the management of POSA document efficacy in decreasing AHI and supine sleep. However, the vast majority of studies are small case series and cohort studies and large good-quality randomized controlled trials with long-term follow-up are lacking. It is not clear whether some PT techniques are superior to others in minimizing supine sleep and optimizing reductions in AHI. In the short term, PT appears to be costeffective when compared to CPAP but nowadays, it is difficult to conclude whether PT is cost-effective in the long term [70] .
Conclusion
Up to now, the different aspects of the pathophysiology of OSA have not been systematically considered when selecting therapeutic options which are usually proposed without taking into account the patient's phenotyping using PTs. The PALM scale overcomes a Bone-size-fit-all^CPAP approach and introduces the concept of customized therapy for OSA patients but it cannot be ignored that amongst non-CPAP therapies, pharmacological options to modify LG/AT/UAG lack robust validation studies. The sleep research laboratory phenotyping of PTs will not be available in the clinical routine in the near future and this determines the need to establish available diagnostic pathways for the identification of different PTs. In the current review, the authors report the data, beyond the scope and context of the original studies, which are useful to qualitatively define the PTs of the patient with OSA using standard PSG/PM recordings. Moreover, other clinical PSG/PM indexes and patterns have been discussed, taking into account that their knowledge could significantly influence the therapeutic OSA management.
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